US Broker Ratings

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring Value Amidst Challenges with a 4.67% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY), a key player in the healthcare sector, particularly in medical instruments and supplies, is drawing investor attention with its robust 4.67% dividend..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 68% Potential Upside for Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is catching the attention of investors looking for high-growth opportunities within the healthcare sector. As a clinical-stage pharmaceutical company, Centessa is..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analyzing a 16.71% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in managing senior living communities across the United States. With a market..

Organon & Co. (OGN) Stock Analysis: Exploring a Potential 18.3% Upside in Healthcare

Organon & Co. (NYSE: OGN), a noteworthy player in the general drug manufacturing sector, presents an intriguing opportunity for investors interested in the healthcare landscape. With..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 69.80% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of genetic innovation with its cutting-edge CRISPR/Cas9 platform, targeting a vast array of serious human diseases. As..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Reveals a 25% Upside Potential in a Rising Biotech Star

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its promising developments in the biotechnology sector, particularly in the realm of neurological treatments. With..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 13.75% Potential Upside in Healthcare’s Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (CNMD) an intriguing proposition. With a market capitalization of $1.29 billion, this American medical device..

Certara, Inc. (CERT) Investor Outlook: Exploring a Promising 72.59% Potential Upside

Certara, Inc. (NASDAQ: CERT), a company positioned within the healthcare sector, specifically in health information services, is capturing investor interest with its compelling growth narrative and..

Tarsus Pharmaceuticals, Inc. (TARS)

⚠️ No article content returned.

..

Investor Outlook: Ascentage Pharma Group Internat (AAPG) Poised for 93.62% Upside with Strong Analyst Support

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is capturing the attention of investors with its innovative pipeline focused on cancer..

Warby Parker Inc. (WRBY) Stock Analysis: 12.88% Potential Upside Beckons Investors

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, continues to attract investor interest with its innovative business model and impressive growth trajectory...

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 11% Potential Upside in the Medical Devices Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices industry, is capturing investor attention with its intriguing mix of growth potential and compelling market..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Potential 32% Upside Captures Investor Attention

As investors continuously seek promising opportunities in the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) stands out with a compelling potential upside of 32.16%, according..

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Reveals 34% Upside Potential Amid Robust CNS Pipeline

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company specializing in central nervous system (CNS) disorders, is gaining attention from investors looking for promising growth potential in..

Galapagos NV (GLPG) Stock Analysis: Navigating a Volatile Biotech Landscape with a -16.40% Investor Outlook

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, has carved out a niche in the healthcare sector with its focus on innovative treatments in oncology and..

GeneDx Holdings Corp. (WGS): Investor Outlook Highlights 86.32% Potential Upside Amid Robust Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a key player in the diagnostics and research sector, has captured investor attention with its promising growth potential and a significant..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 31% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a significant player in the healthcare sector focused on diagnostic testing solutions, presents an intriguing opportunity for investors eyeing the medical devices..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: An 82.74% Potential Upside Drives Market Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is gaining traction within the biotechnology sector, primarily due to its promising portfolio of novel therapeutics targeting rare endocrine diseases. With..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling Robust Growth Potential with a 57% Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of biopharmaceutical innovation, focusing on the discovery and development of therapies for neurodegenerative and lysosomal storage diseases...

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Founded in 2013..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds